V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013787 | 270009388 | 1.5 | 88.4 | Curative (C) | 2016-02-15 | 2016-02-15 | Cetuximab + Radiotherapy Maint | N | N | 270015735 | CETUXIMAB + RT |
| 270013788 | 270009388 | null | null | Palliative (P) | 2013-02-16 | 2013-03-11 | Trifluridine + Tipiracil | N | N | 270015735 | TRIFLURIDINE + TIPIRACIL |
| 270013789 | 270016914 | 1.6 | 80.4 | Curative (C) | 2014-09-19 | 2014-09-19 | CHOP R | N | null | 270015738 | CHOP R |
| 270013790 | 270009389 | 1.74 | 63.1 | Curative (C) | 2017-02-01 | 2017-03-03 | CHLVPP | null | null | 270015743 | CHLVPP |
| 270013791 | 270009389 | 1.77 | 71.6 | Disease modification (D) | 2015-03-07 | 2015-03-09 | null | 02 | N | 270015743 | NOT MATCHED |
| 270013792 | 270009389 | null | 83 | Palliative (P) | 2014-09-22 | 2014-09-22 | Capecitabine (21 day) + Irinotecan | N | N | 270015743 | CAPECITABINE + IRINOTECAN |
| 270013793 | 270009389 | 1.8 | 58.6 | Palliative (P) | 2018-03-14 | 2018-03-14 | Trifluridine + Tipiracil | 2 | N | 270015743 | TRIFLURIDINE + TIPIRACIL |
| 270013794 | 270020078 | 1.65 | 92.4 | Curative (C) | 2015-11-10 | 2015-11-11 | Cetuximab + Radiotherapy Maint | N | N | 270015754 | CETUXIMAB + RT |
| 270013795 | 270020078 | null | 56 | Adjuvant (A) | 2019-01-08 | 2019-01-29 | Capecitabine (21 day) + Irinotecan | N | Y | 270015754 | CAPECITABINE + IRINOTECAN |
| 270013796 | 270020078 | 1.75 | 53.5 | Curative (C) | null | 2016-01-26 | CISPLATIN + FLUOROURACIL | N | N | 270015754 | CISPLATIN + FLUOROURACIL |
| 270013797 | 270020078 | null | 88 | null | 2015-06-28 | 2015-07-04 | CETUXIMAB + RT | N | N | 270015754 | CETUXIMAB + RT |
| 270013798 | 270014393 | 1.67 | 50 | Curative (C) | 2015-12-07 | 2015-12-13 | CYCLOPHOSPHAMIDE + MITOXANTRONE + VINCRISTINE | 02 | N | 270015765 | NOT MATCHED |
| 270013799 | 270009391 | 1.6 | 85.4 | Curative (C) | 2018-07-05 | 2018-07-06 | CHOP R - 21 days | N | N | 270015766 | CHOP R |
| 270013800 | 270014394 | 1.69 | 56.7 | Curative (C) | 2014-07-24 | 2014-07-29 | CHOP R | N | N | 270015768 | CHOP R |
| 270013801 | 270009392 | 1.61 | 52.5 | Palliative (P) | 2019-05-12 | 2019-05-15 | Trifluridine + Tipiracil | null | null | 270015769 | TRIFLURIDINE + TIPIRACIL |
| 270013802 | 270009395 | 1.55 | 85 | Palliative (P) | 2015-06-17 | 2015-06-30 | Trifluridine + Tipiracil | N | N | 270015772 | TRIFLURIDINE + TIPIRACIL |
| 270013803 | 270009396 | 1.78 | 50 | Curative (C) | 2015-03-27 | 2017-11-16 | DHAP | N | N | 270015773 | DHAP |
| 270013804 | 270009396 | 1.7 | 57.2 | Curative (C) | 2015-03-27 | 2016-10-21 | CISPLATIN + FLUOROURACIL | N | Y | 270015773 | CISPLATIN + FLUOROURACIL |
| 270013805 | 270009396 | 1.68 | 0 | Curative (C) | 2018-08-21 | 2018-08-23 | DHAP | 2 | N | 270015773 | DHAP |
| 270013806 | 270009398 | null | 78.5 | Disease modification (D) | 2015-03-18 | 2015-04-11 | CHOP R - 21 days | null | N | 270015779 | CHOP R |
| 270013807 | 270009399 | null | null | Curative (C) | 2013-11-07 | 2013-11-07 | Cetuximab + Radiotherapy Maint | N | N | 270015782 | CETUXIMAB + RT |
| 270013808 | 270009400 | 1.8 | 86.9 | Palliative (P) | 2014-04-13 | 2014-04-20 | Trifluridine + Tipiracil | 02 | N | 270015784 | TRIFLURIDINE + TIPIRACIL |
| 270013809 | 270009400 | null | null | Curative (C) | 2014-05-01 | 2014-05-22 | Trifluridine + Tipiracil | null | N | 270015784 | TRIFLURIDINE + TIPIRACIL |
| 270013810 | 270009400 | 1.75 | 88.1 | Palliative (P) | 2017-07-07 | 2017-07-07 | Trifluridine + Tipiracil | 2 | N | 270015784 | TRIFLURIDINE + TIPIRACIL |
| 270013811 | 270009400 | null | null | Curative (C) | null | 2013-09-12 | DHAP | N | Y | 270015784 | DHAP |
| 270013812 | 270009400 | 1.76 | 51.3 | Palliative (P) | 2015-07-24 | 2015-07-24 | Capecitabine (21 day) + Irinotecan | 02 | N | 270015784 | CAPECITABINE + IRINOTECAN |
| 270013813 | 270018377 | 1.72 | 111 | Adjuvant (A) | 2014-05-20 | 2014-05-20 | Trifluridine + Tipiracil | 02 | N | 270015795 | TRIFLURIDINE + TIPIRACIL |
| 270013814 | 270019934 | 1.74 | null | Adjuvant (A) | 2017-04-29 | 2017-04-29 | CHOP R - 21 days | null | null | 270015806 | CHOP R |
| 270013815 | 270009405 | null | 65.9 | Palliative (P) | 2016-05-18 | 2016-08-10 | FLUOROURACIL | N | N | 270015814 | FLUOROURACIL |
| 270013816 | 270009406 | 1.6 | 57.2 | Palliative (P) | 2014-12-17 | 2014-12-31 | Trifluridine + Tipiracil | 02 | N | 270015815 | TRIFLURIDINE + TIPIRACIL |
| 270013817 | 270009407 | 1.82 | 97.9 | Palliative (P) | 2015-07-09 | 2015-08-09 | HD Lymph Pred EuroNet-PHL-LP1 CVP | N | N | 270015816 | NOT MATCHED |
| 270013818 | 270009408 | null | 75.4 | Neo-adjuvant (N) | 2017-07-27 | 2017-07-30 | Capecitabine 35days + RT | 02 | null | 270015818 | CAPECITABINE + RT |
| 270013819 | 270014399 | 1.8 | 80 | Adjuvant (A) | 2018-06-08 | 2018-06-11 | CHLVPP | N | N | 270015819 | CHLVPP |
| 270013820 | 270014399 | null | 72 | Palliative (P) | 2017-08-10 | 2017-08-10 | CISPLATIN + FLUOROURACIL | null | null | 270015819 | CISPLATIN + FLUOROURACIL |
| 270013821 | 270009413 | 1.73 | 55.4 | Palliative (P) | 2015-04-05 | 2015-04-18 | CHOP R - 21 days | N | N | 270015824 | CHOP R |
| 270013822 | 270009413 | 1.78 | 47.1 | Palliative (P) | 2014-09-14 | 2014-09-18 | FLUOROURACIL | N | N | 270015824 | FLUOROURACIL |
| 270013823 | 270009414 | 1.77 | 47.6 | null | 2015-06-19 | 2015-06-25 | Capecitabine (14 day) + Irinotecan | N | null | 270015828 | CAPECITABINE + IRINOTECAN |
| 270013824 | 270014401 | 1.7 | 83.4 | Palliative (P) | 2018-04-01 | 2018-04-01 | Trifluridine + Tipiracil | N | N | 270015829 | TRIFLURIDINE + TIPIRACIL |
| 270013825 | 270016922 | null | 76 | Curative (C) | 2013-05-24 | 2013-05-24 | CETUXIMAB + RT | N | N | 270015830 | CETUXIMAB + RT |
| 270013826 | 270016922 | 1.62 | 92.4 | Adjuvant (A) | 2017-03-30 | 2017-03-31 | Trifluridine + Tipiracil | 02 | Y | 270015830 | TRIFLURIDINE + TIPIRACIL |
| 270013827 | 270009415 | 1.6 | 56.95 | Adjuvant (A) | 2014-08-29 | 2014-09-05 | CHLVPP | 02 | N | 270015841 | CHLVPP |
| 270013828 | 270009416 | 1.77 | 44 | Palliative (P) | 2014-10-02 | 2015-02-26 | Bevacizumab + Oxaliplatin +MdG | N | N | 270015843 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013829 | 270009420 | 1.75 | null | Neo-adjuvant (N) | 2014-10-10 | 2014-10-24 | Capecitabine (14 day) + Irinotecan | N | N | 270015844 | CAPECITABINE + IRINOTECAN |
| 270013830 | 270009420 | null | 73 | Adjuvant (A) | 2014-05-17 | 2014-07-29 | Trifluridine + Tipiracil | null | null | 270015844 | TRIFLURIDINE + TIPIRACIL |
| 270013831 | 270009420 | 1.52 | 74.4 | Neo-adjuvant (N) | 2013-10-14 | 2013-11-07 | CAPECITABINE + RT | 2 | N | 270015844 | CAPECITABINE + RT |
| 270013832 | 270009421 | null | 72.6 | Curative (C) | null | 2013-12-07 | null | N | N | 270015853 | NOT MATCHED |
| 270013833 | 270016924 | 1.65 | null | null | 2017-09-28 | 2017-10-17 | ALCL ALCL 99 Closed BM 1, 2 or 3 | 02 | Y | 270015857 | NOT MATCHED |
| 270013834 | 270016924 | null | null | Adjuvant (A) | 2018-02-10 | 2018-02-13 | Trifluridine + Tipiracil | N | N | 270015857 | TRIFLURIDINE + TIPIRACIL |
| 270013835 | 270009422 | 1.77 | 71.45 | Neo-adjuvant (N) | 2015-07-01 | 2015-07-01 | Capecitabine 35days + RT | N | N | 270015859 | CAPECITABINE + RT |
| 270013836 | 270009423 | 1.67 | 108 | Adjuvant (A) | 2017-12-23 | 2017-12-27 | DHAP | 02 | Y | 270015860 | DHAP |